Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Berruti

Showing results (131-140 of 315) with videos related to

Pageof 32
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 19, 2022
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysisFausto Petrelli, Massimiliano Nardone, Francesca Trevisan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 28, 2018
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomasSimona Vatrano, Marco Volante, Eleonora Duregon, et al.
Plos One|April 3, 2019
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacyFrancesca Consoli, Ausilia Maria Manganoni, Salvatore Grisanti, et al.
Cells|March 13, 2024
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical StudyElisa Rossini, Mariangela Tamburello, Andrea Abate, et al.
Tomography (Ann Arbor, Mich.)|July 26, 2024
Fat Fraction Extracted from Whole-Body Magnetic Resonance (WB-MR) in Bone Metastatic Prostate Cancer: Intra- and Inter-Reader Agreement of Single-Slice and Volumetric MeasurementsGiorgio Maria Agazzi, Nunzia Di Meo, Paolo Rondi, et al.
Endocrine-Related Cancer|November 14, 2025
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective studyMarta Laganà, Fabio Gallo, Maddalena Salvetti, et al.
Anticancer Research|August 2, 2019
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based AnalysisCarlotta Palumbo, Angela Pecoraro, Sophie Knipper, et al.
Cancers|April 17, 2020
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center StudyGuido Alberto Massimo Tiberio, Vittorio Ferrari, Zeno Ballarini, et al.
Bone|August 29, 2006
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor loadDaniele Generali, Alfredo Berruti, Marco Tampellini, et al.
Pharmacology|August 11, 2017
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic ActivityFrancesca Bedussi, Diego Galli, Martina Fragni, et al.
Pageof 32

Showing results (131-140 of 315) with videos related to

Sort By:
Pageof 32
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 19, 2022
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysisFausto Petrelli, Massimiliano Nardone, Francesca Trevisan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 28, 2018
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomasSimona Vatrano, Marco Volante, Eleonora Duregon, et al.
Plos One|April 3, 2019
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacyFrancesca Consoli, Ausilia Maria Manganoni, Salvatore Grisanti, et al.
Cells|March 13, 2024
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical StudyElisa Rossini, Mariangela Tamburello, Andrea Abate, et al.
Tomography (Ann Arbor, Mich.)|July 26, 2024
Fat Fraction Extracted from Whole-Body Magnetic Resonance (WB-MR) in Bone Metastatic Prostate Cancer: Intra- and Inter-Reader Agreement of Single-Slice and Volumetric MeasurementsGiorgio Maria Agazzi, Nunzia Di Meo, Paolo Rondi, et al.
Endocrine-Related Cancer|November 14, 2025
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective studyMarta Laganà, Fabio Gallo, Maddalena Salvetti, et al.
Anticancer Research|August 2, 2019
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based AnalysisCarlotta Palumbo, Angela Pecoraro, Sophie Knipper, et al.
Cancers|April 17, 2020
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center StudyGuido Alberto Massimo Tiberio, Vittorio Ferrari, Zeno Ballarini, et al.
Bone|August 29, 2006
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor loadDaniele Generali, Alfredo Berruti, Marco Tampellini, et al.
Pharmacology|August 11, 2017
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic ActivityFrancesca Bedussi, Diego Galli, Martina Fragni, et al.
Pageof 32